Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearching for a Wegovy how-to video makes complete sense before your first injection — most people feel a lot calmer once they've seen the pen in action. Wegovy (semaglutide) is a once-weekly subcutaneous injection, and the pre-filled pen is genuinely straightforward once you know the steps. Because it's a prescription-only medicine, your first injection should always follow guidance from your prescriber and the Patient Information Leaflet supplied with your treatment. The steps below explain what to look for in any how-to video, and what official resources are available from Novo Nordisk and the NHS.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A trustworthy wegovy video walks you through each part of the pen before anything touches your skin. It should start with a check: is the medicine clear and colourless? Any cloudiness or visible particles means you should not use that pen and should contact your pharmacy. The video will then show you removing the base cap, choosing your injection site, and cleaning the area, many people use an alcohol swab, which you can read about on the Wegovy injection technique page.
Next it should demonstrate pressing the pen firmly against the skin at a 90-degree angle, activating the dose, and holding it in place until the injection is complete. The pen clicks when the dose has been delivered, and a yellow indicator shows in the window. Once you've confirmed the dose is done, the needle retracts automatically, you don't manually recap anything. A good video then covers safe disposal: the entire pen goes into a sharps container, not the household bin.
One thing to watch for: some older videos show technique for previous pen formats. Always check that the video matches the specific pen version you've been dispensed, and when in doubt, the semaglutide medicine guide or your pharmacist can confirm which version applies to you.
The manufacturer, Novo Nordisk, hosts patient-facing injection guidance on their UK website and YouTube channel. These are produced alongside the Summary of Product Characteristics and are updated when the pen format changes, which matters now that the Wegovy 7.2mg single-dose pen, approved by the MHRA in April 2026, has a different mechanism and built-in covered needle from the earlier 2.4mg pens.
The NHS also signposts patients to the leaflet and manufacturer resources via the NHS semaglutide medicine page, which is a good first stop if you're unsure whether a video you've found is reliable. Videos shared on social media or by unverified sellers should be treated with scepticism, they may show an older pen, incorrect technique, or, in the case of counterfeit products, a pen that isn't genuine Wegovy at all.
If you're transferring your prescription to a new pharmacy and want to confirm you're handling the right pen correctly, our Wegovy administration guide covers what to check and when to ask for support.
Yes, in a practical sense. Subcutaneous injection means the medicine is delivered into the fatty tissue just beneath the skin, not into muscle, and not intradermally. If the pen isn't pressed flush against the skin, or the injection site is rotated too infrequently, you may get more injection-site discomfort or inconsistent absorption. Neither is dangerous in the way a wrong intravenous technique would be, but they can affect how comfortable treatment feels week to week.
Nausea is the most commonly reported side effect of semaglutide, particularly in the early weeks of treatment and after dose increases, and it has nothing to do with injection technique, it's the medicine's action on the gut. You can read a fuller breakdown of the gastrointestinal side-effect profile, and when to contact your prescriber, in the semaglutide injection guide. The NHS England weight management injections resource also covers what to expect in the first weeks of treatment, including guidance on contraception, HRT and surgery, practical topics your prescriber should cover at the outset.
One thing our prescribers hear fairly often: people who've watched a video beforehand feel confident on the day their pen arrives. Doing it with the lights on, at a relaxed moment (not last thing at night) tends to make the first injection a non-event. Worth planning for, if you can.
The Patient Information Leaflet included in your Wegovy packaging is the definitive written reference for your specific pen and dose, it covers storage windows, missed dose instructions and what to do if you think you've had an adverse reaction. For anything the leaflet doesn't answer, your prescriber is the right person to ask, not a forum thread or a comment under a YouTube video.
If you're considering starting Wegovy and want to understand whether it might be suitable for you, the Wegovy eligibility and access page outlines the licensed criteria. A broader overview of the weight-loss treatment options available through nume is on the treatment overview page. And if you have a specific question for our clinical team before or during treatment, the contact page connects you directly to aftercare support, seven days a week.
When you're ready to take the next step, you can check your eligibility with a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, with no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.